Pirfenidone in Adult Hospitalized Patients With COVID-19

PHASE3CompletedINTERVENTIONAL

Enrollment

168

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

March 4, 2023

Study Completion Date

March 30, 2023

Conditions

COVID-19 Pneumonia

Interventions

DRUG

Pirfenidone Oral Product

Pirfenidone 200mg tid for first week; subsequently, 400mg tid for 2 months

DRUG

Pirfenidone placebo

Trial Locations (1)

China-Japan Friendship Hospital, Beijing

All Listed Sponsors

lead

Capital Medical University

OTHER